ImmunoPrecise Antibodies Ltd. Quarterly Entity Common Stock, Shares Outstanding from Q1 2021 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ImmunoPrecise Antibodies Ltd. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2021 to Q1 2023.
  • ImmunoPrecise Antibodies Ltd. Entity Common Stock, Shares Outstanding for the quarter ending April 30, 2023 was 25.1M shares, a 2.34% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 25.1M +573K +2.34% Apr 30, 2023 40-F 2023-07-10
Q1 2022 24.5M +5.31M +27.7% Apr 30, 2022 40-F 2022-07-29
Q1 2021 19.2M Apr 30, 2021 40-F/A 2021-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.